Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices

• Main Authors: Bożena Szyguła-Jurkiewicz (Author), Wioletta Szczurek-Wasilewicz (Author), Mariusz Gąsior (Author), Izabela Copik (Author), Justyna Małyszek-Tumidajewicz (Author), Michał Skrzypek (Author), Ewa Romuk (Author), Michał Zembala (Author), Marian Zembala (Author), Piotr Przybyłowski (Author)
• Format: Book
• Published: MDPI AG, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Left ventricular assist device (LVAD) is well established as an alternative treatment for end-stage heart failure (HF) patients. The aim of the study was to determine the prognostic value of oxidative stress markers and the modified Model for End-Stage Liver Disease (modMELD) in patients receiving b...